CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Principal Accounting Officer sold 250 shares at $39.93 ($9,983)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 1,878 shares (option exercise)
- 4 Option exercise Director acquired 1,878 shares (option exercise)
- 4 Option exercise Director acquired 1,878 shares (option exercise)
- 4 Option exercise Director acquired 1,878 shares (option exercise)
- 4 Option exercise Director acquired 1,878 shares (option exercise)
- 4 Option exercise Director acquired 1,878 shares (option exercise)
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief Medical Officer sold 3,583 shares at $50.01 ($179,200)
- S-3ASR Offering Registration Statement
- POSASR Other POSASR
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,927 shares (to pay taxes)
Page 29 of 66 · 1,304 filings